Form 4: Wilkinson Peter J reports multiple insider transactions in LH

Rhea-AI Filing Summary

Wilkinson Peter J reported multiple insider transaction types in a Form 4 filing for LH. The filing lists transactions totaling 1,598 shares at a weighted average price of $289.89 per share. Following the reported transactions, holdings were 2,128 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkinson Peter J

(Last) (First) (Middle)

231 MAPLE AVENUE

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		536	A	(1)	2,564.2194	D
Common Stock	02/11/2026		F(2)		160	D	$289.89	2,404.2194	D
Common Stock	02/11/2026		M		160	A	(1)	2,564.2194	D
Common Stock	02/11/2026		F(2)		46	D	$289.89	2,518.2194	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			536	(3)	(3)	Common Stock	536	$0	2,128(4)	D
Restricted Stock Unit	(1)	02/11/2026		M			160	(3)	(3)	Common Stock	160	$0	1,968(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Peter J. Wilkinson	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Labcorp (LH) report for Peter J. Wilkinson?

Labcorp reported that SVP and Chief Accounting Officer Peter J. Wilkinson exercised restricted stock units into common stock. Some of the newly issued shares were withheld to cover tax obligations, rather than sold on the open market, as disclosed in the Form 4.

How many Labcorp (LH) common shares did Peter J. Wilkinson acquire on February 11, 2026?

On February 11, 2026, Peter J. Wilkinson acquired 536 and 160 Labcorp common shares through RSU exercises. These were non-cash derivative conversions, reflecting the vesting of equity awards granted as part of his compensation package as a senior executive.

Were any of Peter J. Wilkinson’s Labcorp (LH) shares sold in the market?

No open-market sales were reported. The Form 4 shows dispositions coded “F,” meaning 160 and 46 shares were withheld at $289.89 per share solely to satisfy tax withholding obligations tied to the RSU vesting, not discretionary share sales.

How many Labcorp (LH) common shares does Peter J. Wilkinson own after these transactions?

After the reported transactions, Peter J. Wilkinson directly owns 2,518.2194 Labcorp common shares. This figure reflects his updated direct beneficial ownership following the RSU exercises and share withholdings to cover associated tax liabilities on February 11, 2026.

What restricted stock unit (RSU) holdings does Peter J. Wilkinson retain at Labcorp (LH)?

Wilkinson continues to hold significant RSU positions, including blocks of 2,128 and 1,968 units. Each RSU represents a contingent right to receive one Labcorp common share, with these grants vesting in three equal annual installments starting February 11, 2026.

What do the Form 4 transaction codes M and F mean for Labcorp (LH)?

Code “M” indicates exercise or conversion of derivative securities, such as RSUs, into common stock. Code “F” indicates shares withheld to pay exercise price or tax liabilities. In this filing, Labcorp shows both RSU exercises and tax-withholding share dispositions.